EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diphenoquinone, a small-HDL neogenesis accelerator, concurrently docks with cholesterol or POPC to human ATP-binding cassette transporter ABCA1

Maki Tsujita iD, Leticia Alves da Silva iD, Kosuke Nakasuka iD, Junki Yamamoto iD, Robert C Ford iD, Thomas Stockner iD

Biochemistry and Cell Biology · 2026

DOI: 10.1139/bcb-2026-0043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2026. Verfasst von Maki Tsujita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter 1, Cholesterol, Phosphatidylcholines, Benzoquinones. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid for Outstanding Research Group Support Program in Nagoya City University, Japan Agency for Medical Research and Development, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-density lipoprotein (HDL) functionality has emerged as a key determinant of residual cardiovascular risk despite advances in low-density lipoprotein-cholesterol lowering therapies. Small HDL particles, generated through ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux, are particularly effective in promoting cholesterol removal from macrophage foam cells and are associated with reduced atherosclerotic risk. Probucol, a lipid-lowering drug, inhibits ABCA1-dependent HDL biogenesis, whereas its major metabolite, 3,3′,5,5′-tetra-tert-butyldiphenoquinone (DQ), preserves the generation of small HDL particles. However, the molecular basis for these distinct effects has remained unclear. To investigate the structural mechanisms underlying ABCA1-mediated lipid export, we performed molecular docking analyses using the human ABCA1 structure (Protein Data Bank, PDB: 5XJY) and the Genetic Optimization for Ligand Docking in silico docking platform. Cholesterol and 1-palmitoyl-2-oleoyl-phosphatidylcholine docking poses were successfully identified in DQ-bound ABCA1. In contrast, no ligand-binding poses were detected in probucol-bound ABCA1. These findings suggest that DQ preserves the lipid-recognition and transport properties of ABCA1, whereas probucol disrupts ligand accommodation within the transporter. This study provides the first atomic-level insight into the interactions among ABCA1, cholesterol, probucol, and DQ, offering a structural explanation for their distinct effects on HDL biogenesis and identifying a potential framework for developing novel HDL-targeted therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP Binding Cassette Transporter 1CholesterolPhosphatidylcholinesBenzoquinonesLipoproteins, HDLHumansMolecular Docking SimulationProbucol

Stichwörter der Autor:innen

ABCA1MDL-29311cholesteroldiphenoquinonedockingprobucol

Substanzen

ATP Binding Cassette Transporter 1CholesterolABCA1 protein, humanPhosphatidylcholines1-palmitoyl-2-oleoylphosphatidylcholineBenzoquinonesLipoproteins, HDLProbucol

Autor:innen und Institutionen

  • Department of Biochemistry, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
  • Medical University of Vienna, Center for Physiology and Pharmacology, Institute of Pharmacology, Schwarzspanierstraße, 17A 1090 Vienna, Austria.
  • Department of Cardiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
  • Division of Cardiology, Department of Medicine, University of California, San Francisco, Helen Diller Medical Center, Parnassus Heights Campus, 505 Parnassus Avenue, San Francisco, CA 94143, USA.
  • School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Oxford Rd, Manchester M13 9PL, UK.

ORCID-Profile: Maki Tsujita, Leticia Alves da Silva, Kosuke Nakasuka, Junki Yamamoto, Robert C Ford, Thomas Stockner

Förderung

  • Grant-in-Aid for Outstanding Research Group Support Program in Nagoya City University
  • Japan Agency for Medical Research and Development
  • European Union
  • Ministry of Education, Culture, Sports, Science and Technology; Health, Welfare and Labor of Japan

Zitieren

APA

Tsujita, M., Alves da Silva, L., Nakasuka, K., Yamamoto, J., Ford, R., & Stockner, T. (2026). Diphenoquinone, a small-HDL neogenesis accelerator, concurrently docks with cholesterol or POPC to human ATP-binding cassette transporter ABCA1. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2026-0043

Vancouver

Tsujita M, Alves da Silva L, Nakasuka K, Yamamoto J, Ford R, Stockner T. Diphenoquinone, a small-HDL neogenesis accelerator, concurrently docks with cholesterol or POPC to human ATP-binding cassette transporter ABCA1. Biochemistry and Cell Biology. 2026. doi:10.1139/bcb-2026-0043

BibTeX
@article{Tsujita2026,
  author = {Tsujita, Maki and Alves da Silva, Leticia and Nakasuka, Kosuke and Yamamoto, Junki and Ford, Robert C and Stockner, Thomas},
  title = {Diphenoquinone, a small-HDL neogenesis accelerator, concurrently docks with cholesterol or POPC to human ATP-binding cassette transporter ABCA1},
  journal = {Biochemistry and Cell Biology},
  year = {2026},
  doi = {10.1139/bcb-2026-0043}
}
Kostenlos starten →